Drug intelligence / Profile preview

macrogol + citrate + simeticone + bisacodyl

Development stage
Unknown
Lead developer
Promefarm
Modality
Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol + citrate + simeticone + bisacodyl (also known as PEG-CS plus bisacodyl) is a low-volume bowel preparation regimen primarily indicated for colonic cleansing prior to colonoscopy or computed tomography colonography (CTC). The formulation consists of a 2-liter polyethylene glycol (PEG) solution enriched with citrates and simethicone, administered in conjunction with bisacodyl tablets. The components work through distinct yet complementary mechanisms: PEG and citrates act as osmotic laxatives to increase intestinal water retention and stool volume; bisacodyl serves as a stimulant laxative to enhance colonic motility; and simethicone acts as an anti-foaming agent to eliminate gas bubbles that might otherwise obscure visualization during endoscopic procedures. This combination is designed to provide equivalent bowel cleansing efficacy to traditional 4-liter PEG preparations while significantly improving patient tolerability, compliance, and overall acceptability due to the reduced fluid volume.

Brand names
Lovol-esse
Other names
PEG-CS plus bisacodylPEG-citrate-simethicone plus bisacodylpolyethylene glycol + citrate + simeticone + bisacodylmacrogol 4000 + citrate + simeticone + bisacodyl
02

Targets

AC (Adenylyl cyclase family)AQP3 (Aquaporin-3 channel protein)

Beyond the preview

Go deeper on macrogol + citrate + simeticone + bisacodyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on macrogol + citrate + simeticone + bisacodyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call